Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 12:21:35 PM Tue, 14 Apr 2020   Contact Information Sendurai Mani Associated Profiles  Associate Professor, Translational Molecular Pathology, Co-Director, Metastasis Research Center, Center for Stem Cell & Developmental Biology, UT MD Anderson Cancer Center   MDA LSP9.2001 (Unit 2951)    smani@mdanderson.org     713-792-9638    Web Link    Lab Webpage    Epithelial-Mesenchymal Transition, Breast Neoplasms, Neoplasm Metastasis, Neoplastic Stem Cells, Neoplasms, Mesenchymal Stromal Cells, Stem Cells, Untranslated RNA    Associated Profiles Research and Expertise Appointments  Research and Expertise Research Interests   Despite the advent of advanced diagnosis and treatment options, metastasis remain accounts for more than 90 percent of deaths among cancer patients. Unfortunately, there are no treatments available for patients with metastasis. We and others have demonstrated that the carcinoma cells, which are initially confined to the primary tumor site by the continued expression of cell-cell adhesion molecules, acquires mesenchymal morphology, increased migration, invasion and metastatic properties by activating a latent embryonic program, known as epithelial-mesenchymal transition (EMT). In addition, during metastasis, cancer cells leaving the primary site recreate tumor histopathologically similar to their tissue of origin at the metastatic site. Therefore, we hypothesized and demonstrated that the cancer cells also acquire stem cell properties via EMT in addition to migratory and invasive capacities. Because both cancer stem cells (CSCs) and the EMT program are independently shown to be responsible for promoting metastasis and the acquisition of resistance to standard of care therapies and we have found that these two are indeed intertwined, we put forward the notion that the EMT-signaling pathways may offer a diagnostic and therapeutic window for detecting and treating metastasis. At present, our laboratory is investigating the biology of metastasis at the molecular level and developing ways to diagnose and treat metastasis.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Appointments Title Department / School Institution Associate Professor Translational Molecular Pathology MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.